Cannabis Report
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

Listen to the call. The CEO explains why.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Inoviorulez Member Profile
 
Followed By 27
Posts 1,483
Boards Moderated 2
Alias Born 09/25/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2018 5:06:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/12/2018 4:32:34 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/10/2018 3:50:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/7/2018 6:26:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/7/2018 6:25:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/7/2018 6:24:14 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/7/2018 5:31:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2018 4:33:16 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 8/31/2018 4:35:00 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 8/31/2018 4:33:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/28/2018 4:34:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2018 7:33:49 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2018 5:33:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/14/2018 5:32:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2018 4:39:40 PM
Annual Report (10-k) Edgar (US Regulatory) - 7/27/2018 5:03:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2018 4:32:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/27/2018 9:02:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2018 5:02:40 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/15/2018 7:49:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/15/2018 7:44:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 6:04:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 6:03:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:59:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2018 5:59:49 PM
Inoviorulez   Friday, 11/10/17 07:57:59 PM
Re: gestalt2 post# 18107
Post # of 29048 
Listen to the call. The CEO explains why. The FDA changed their minds. The FDA changed their minds after they saw the submitted results/data. The FDA decided that for the data to be clinically relevant Cytodyn would have to have 50 patients total for analysis. Plain and simple the FDA changed their minds along the way.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist